These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 23412423)
1. What is the clinical value of cancer stem cell markers in gliomas? Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas. Dahlrot RH Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629 [TBL] [Abstract][Full Text] [Related]
3. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713 [TBL] [Abstract][Full Text] [Related]
4. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. Wu B; Sun C; Feng F; Ge M; Xia L J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234 [TBL] [Abstract][Full Text] [Related]
5. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857 [TBL] [Abstract][Full Text] [Related]
6. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas. Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792 [TBL] [Abstract][Full Text] [Related]
7. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of CD133 and nestin in patients with glioma: a population-based study. Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750 [TBL] [Abstract][Full Text] [Related]
9. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer. Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500 [TBL] [Abstract][Full Text] [Related]
10. The pathological characteristics of glioma stem cell niches. He H; Li MW; Niu CS J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090 [TBL] [Abstract][Full Text] [Related]
11. [Correlative study of distribution of brain tumor stem cell with micro-vascular system]. Li MW; Niu CS Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050 [TBL] [Abstract][Full Text] [Related]
12. Expression of CD133 and other putative stem cell markers in uveal melanoma. Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792 [TBL] [Abstract][Full Text] [Related]
13. Stem cell markers in gliomas. Dell'Albani P Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853 [TBL] [Abstract][Full Text] [Related]
14. Cell surface Nestin is a biomarker for glioma stem cells. Jin X; Jin X; Jung JE; Beck S; Kim H Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267 [TBL] [Abstract][Full Text] [Related]
15. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333 [TBL] [Abstract][Full Text] [Related]
16. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer. Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543 [TBL] [Abstract][Full Text] [Related]
17. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms. Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors. Sabet MN; Rakhshan A; Erfani E; Madjd Z Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000 [TBL] [Abstract][Full Text] [Related]
19. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330 [TBL] [Abstract][Full Text] [Related]
20. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas. Shin JH; Lee YS; Hong YK; Kang CS J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]